Your browser doesn't support javascript.
loading
Childhood cancer mutagenesis caused by transposase-derived PGBD5.
Yamada, Makiko; Keller, Ross R; Gutierrez, Rodrigo Lopez; Cameron, Daniel; Suzuki, Hiromichi; Sanghrajka, Reeti; Vaynshteyn, Jake; Gerwin, Jeffrey; Maura, Francesco; Hooper, William; Shah, Minita; Robine, Nicolas; Demarest, Phillip; Bayin, N Sumru; Zapater, Luz Jubierre; Reed, Casie; Hébert, Steven; Masilionis, Ignas; Chaligne, Ronan; Socci, Nicholas D; Taylor, Michael D; Kleinman, Claudia L; Joyner, Alexandra L; Raju, G Praveen; Kentsis, Alex.
Afiliación
  • Yamada M; Tow Center for Developmental Oncology, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Keller RR; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY, USA.
  • Gutierrez RL; Tow Center for Developmental Oncology, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Cameron D; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY, USA.
  • Suzuki H; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Sanghrajka R; Tow Center for Developmental Oncology, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Vaynshteyn J; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY, USA.
  • Gerwin J; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan.
  • Maura F; Developmental Biology Program, Sloan Kettering Institute, New York, NY, USA.
  • Hooper W; Departments of Neurology and Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Shah M; Departments of Neurology and Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Robine N; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
  • Demarest P; Computational Biology, New York Genome Center, New York, NY, USA.
  • Bayin NS; Computational Biology, New York Genome Center, New York, NY, USA.
  • Zapater LJ; Computational Biology, New York Genome Center, New York, NY, USA.
  • Reed C; Tow Center for Developmental Oncology, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hébert S; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY, USA.
  • Masilionis I; Developmental Biology Program, Sloan Kettering Institute, New York, NY, USA.
  • Chaligne R; Wellcome Trust/Cancer Research UK Gurdon Institute, Cambridge University, Cambridge, UK.
  • Socci ND; Tow Center for Developmental Oncology, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Taylor MD; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY, USA.
  • Kleinman CL; Tow Center for Developmental Oncology, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Joyner AL; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY, USA.
  • Raju GP; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  • Kentsis A; Single-Cell Analytics Innovation Lab, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Sci Adv ; 10(12): eadn4649, 2024 Mar 22.
Article en En | MEDLINE | ID: mdl-38517960
ABSTRACT
Genomic rearrangements are a hallmark of most childhood tumors, including medulloblastoma, one of the most common brain tumors in children, but their causes remain largely unknown. Here, we show that PiggyBac transposable element derived 5 (Pgbd5) promotes tumor development in multiple developmentally accurate mouse models of Sonic Hedgehog (SHH) medulloblastoma. Most Pgbd5-deficient mice do not develop tumors, while maintaining normal cerebellar development. Ectopic activation of SHH signaling is sufficient to enforce cerebellar granule cell progenitor-like cell states, which exhibit Pgbd5-dependent expression of distinct DNA repair and neurodevelopmental factors. Mouse medulloblastomas expressing Pgbd5 have increased numbers of somatic structural DNA rearrangements, some of which carry PGBD5-specific sequences at their breakpoints. Similar sequence breakpoints recurrently affect somatic DNA rearrangements of known tumor suppressors and oncogenes in medulloblastomas in 329 children. This identifies PGBD5 as a medulloblastoma mutator and provides a genetic mechanism for the generation of oncogenic DNA rearrangements in childhood cancer.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Cerebelosas / Meduloblastoma Idioma: En Revista: Sci Adv Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Cerebelosas / Meduloblastoma Idioma: En Revista: Sci Adv Año: 2024 Tipo del documento: Article